MabCure, Inc.
MBCI
$0.0001
$0.000.00%
OTC PK
| 12/31/2011 | 09/30/2011 | 06/30/2011 | 03/31/2011 | 12/31/2010 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 35.48% | 16.47% | 53.02% | 56.62% | -29.85% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 13.44% | -0.67% | 40.48% | 19.99% | -47.56% |
| Operating Income | 194.02% | 0.67% | -40.48% | -19.99% | 47.56% |
| Income Before Tax | -4,499.92% | 40.76% | -80.61% | -32.26% | 48.08% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -4,499.92% | 40.76% | -80.61% | -32.26% | 48.08% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -4,499.92% | 40.76% | -80.61% | -32.26% | 48.08% |
| EBIT | 194.02% | 0.67% | -40.48% | -19.99% | 47.56% |
| EBITDA | 200.17% | -0.78% | -42.87% | -20.75% | 48.80% |
| EPS Basic | -4,382.05% | 42.67% | -75.68% | -28.57% | 50.00% |
| Normalized Basic EPS | 187.50% | 42.55% | -78.26% | -25.81% | 50.00% |
| EPS Diluted | -4,382.05% | 42.67% | -75.68% | -28.57% | 50.00% |
| Normalized Diluted EPS | 187.50% | 42.55% | -78.26% | -25.81% | 50.00% |
| Average Basic Shares Outstanding | 2.50% | 1.71% | 1.16% | 3.02% | 3.34% |
| Average Diluted Shares Outstanding | 2.50% | 1.71% | 1.16% | 3.02% | 3.34% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |